SCHEMBL6601581

SCHEMBL6601581

CCOc1ccc(C(=O)Nc2ccc3c(c2Cl)CN(C(=O)C(F)(F)F)CC3)cc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
NR4A1 P22736 1/20 0.47
LMNA P02545 4/20 0.44
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
POLB P06746 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
TP53 P04637 3/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6601797 0.86 MAPT (0.55) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL8145894 0.85 MAPT (0.38) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL6607827 0.85 MAPT (0.38) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL6602358 0.83 CREBBP (0.43) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL6602418 0.82 ESR1 (0.47) MAPTSMN1; SMN2POLBTP53NPC1
SCHEMBL6602268 0.78 MAPT (0.49) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL6602294 0.76 ESR1 (0.48) MAPTSMN1; SMN2KDM4ECYP3A4CYP2C19
SCHEMBL7657674 0.74 MAPT (0.49) MAPTSMN1; SMN2HSD17B10ALOX15ALOX12
SCHEMBL6601638 0.74 ESR1 (0.46) MAPTSMN1; SMN2LMNAKDM4ECYP2C19
SCHEMBL6604922 0.72 ESR1 (0.48) MAPTSMN1; SMN2TP53MAPK1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP claimed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed